Neuroprotection Impact of Cyclosporin A in Cerebral Infarction "CsAStroke"

Completed

Phase 2 Results N/A

Summary of Purpose

The main objective of this study is to determine whether a single injection of CsA after intravenous thrombolysis can significantly decreased the volume of cerebral infarction at day 30 ± 15 assessed with Flair MRI. Secondary objectives are to determine whether a single injection of CsA after intravenous thrombolysis is safe and effective regarding to death and disability.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 May 2014.

1 Oct 2009 31 Jan 2012 1 Oct 2009 1 Dec 2013 1 Jan 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Norbert NIGHOGHOSSIAN